Corticosteroid Therapy for 2019-nCoV-infected Patients: A Case Series of Eight Mechanically Ventilated Patients

Overview

Journal Clin Case Rep

Date 2021 Jun 4

PMID 34084491

Citations 2

Authors

Mabrouk Al-Rasheedi

Yasir Alhazmi

Nouf Almaqwashi

Alreshidi Mateq Ali

Abdulaziz Kardam

Mohammod Sharaf

Khawaja Husnain Haider

Affiliations

Soon will be listed here.

Abstract

High-dose short-term corticosteroid therapy is effective and produces favorable clinical outcome in patients with severe 2019-nCoV infection who are candidates for mechanical ventilation with close monitor/ing for the adverse effect of corticosteroids.

Citing Articles

Editorial: A Compendium of Recent Research on Stem Cell-Based Therapy for Covid-19.

Hmadcha A, Soria B, Zhao R, Smani T, Valverde I Front Cell Dev Biol. 2021; 9:813384.

PMID: 34970555 PMC: 8713248. DOI: 10.3389/fcell.2021.813384.

Corticosteroid therapy for 2019-nCoV-infected patients: A case series of eight mechanically ventilated patients.

Al-Rasheedi M, Alhazmi Y, Almaqwashi N, Mateq Ali A, Kardam A, Sharaf M Clin Case Rep. 2021; 9(5):e04066.

PMID: 34084491 PMC: 8142400. DOI: 10.1002/ccr3.4066.

References

Pujari R, Thommana M, Ruiz Mercedes B, Serwat A . Therapeutic Options for COVID-19: A Review. Cureus. 2020; 12(9):e10480. PMC: 7496561. DOI: 10.7759/cureus.10480. View

Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A . Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020; 323(16):1574-1581. PMC: 7136855. DOI: 10.1001/jama.2020.5394. View

Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo F, Chong M . Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA. 2020; 323(16):1612-1614. PMC: 7082763. DOI: 10.1001/jama.2020.4326. View

Singhania N, Bansal S, Singhania G . An Atypical Presentation of Novel Coronavirus Disease 2019 (COVID-19). Am J Med. 2020; 133(7):e365-e366. PMC: 7167564. DOI: 10.1016/j.amjmed.2020.03.026. View

Lee K, Yoon S, Jeong G, Kim J, Han Y, Hong S . Efficacy of Corticosteroids in Patients with SARS, MERS and COVID-19: A Systematic Review and Meta-Analysis. J Clin Med. 2020; 9(8). PMC: 7465945. DOI: 10.3390/jcm9082392. View

Li G, De Clercq E . Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov. 2020; 19(3):149-150. DOI: 10.1038/d41573-020-00016-0. View

Huang C, Lin H . Association between adrenal insufficiency and ventilator weaning. Am J Respir Crit Care Med. 2005; 173(3):276-80. DOI: 10.1164/rccm.200504-545OC. View

Saune P, Bryce-Alberti M, Portmann-Baracco A, Alfonso Accinelli R . Methylprednisolone pulse therapy: An alternative management of severe COVID-19. Respir Med Case Rep. 2020; 31:101221. PMC: 7502379. DOI: 10.1016/j.rmcr.2020.101221. View

Al-Rasheedi M, Alhazmi Y, Almaqwashi N, Mateq Ali A, Kardam A, Sharaf M . Corticosteroid therapy for 2019-nCoV-infected patients: A case series of eight mechanically ventilated patients. Clin Case Rep. 2021; 9(5):e04066. PMC: 8142400. DOI: 10.1002/ccr3.4066. View

10.

Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H . Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020; 8(5):475-481. PMC: 7102538. DOI: 10.1016/S2213-2600(20)30079-5. View

11.

Guarner J . Three Emerging Coronaviruses in Two Decades. Am J Clin Pathol. 2020; 153(4):420-421. PMC: 7109697. DOI: 10.1093/ajcp/aqaa029. View

12.

Neupane K, Ahmed Z, Pervez H, Ashraf R, Majeed A . Potential Treatment Options for COVID-19: A Comprehensive Review of Global Pharmacological Development Efforts. Cureus. 2020; 12(6):e8845. PMC: 7386097. DOI: 10.7759/cureus.8845. View

13.

Spinner C, Gottlieb R, Criner G, Lopez J, Cattelan A, Soriano Viladomiu A . Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial. JAMA. 2020; 324(11):1048-1057. PMC: 7442954. DOI: 10.1001/jama.2020.16349. View

14.

Stockman L, Bellamy R, Garner P . SARS: systematic review of treatment effects. PLoS Med. 2006; 3(9):e343. PMC: 1564166. DOI: 10.1371/journal.pmed.0030343. View

15.

Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R . The COVID-19 Cytokine Storm; What We Know So Far. Front Immunol. 2020; 11:1446. PMC: 7308649. DOI: 10.3389/fimmu.2020.01446. View

16.

Mahallawi W, Khabour O, Zhang Q, Makhdoum H, Suliman B . MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Cytokine. 2018; 104:8-13. PMC: 7129230. DOI: 10.1016/j.cyto.2018.01.025. View

17.

Al-Dorzi H, Alsolamy S, Arabi Y . Critically ill patients with Middle East respiratory syndrome coronavirus infection. Crit Care. 2016; 20:65. PMC: 4794852. DOI: 10.1186/s13054-016-1234-4. View

18.

Moore J, June C . Cytokine release syndrome in severe COVID-19. Science. 2020; 368(6490):473-474. DOI: 10.1126/science.abb8925. View

19.

Williams D . Clinical Pharmacology of Corticosteroids. Respir Care. 2018; 63(6):655-670. DOI: 10.4187/respcare.06314. View

20.

Zheng C, Hafezi-Bakhtiari N, Cooper V, Davidson H, Habibi M, Riley P . Characteristics and transmission dynamics of COVID-19 in healthcare workers at a London teaching hospital. J Hosp Infect. 2020; 106(2):325-329. PMC: 7384992. DOI: 10.1016/j.jhin.2020.07.025. View